Loading company…
Viela Bio is a Maryland biotechnology company that develops and commercializes therapies for autoimmune neuromuscular disorders.
Viela Bio, Inc. was founded in 2018 and is based in Gaithersburg and Rockville, Maryland, US. It raised Series B funding in June 2019 and listed on NASDAQ in October 2019. The company had its first FDA-approved treatment in June 2020, and Horizon Therapeutics acquired all of Viela Bio's common stock in February 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in